RE: Sub 1 pence13 Dec 2018 21:22
Sedoc
Obviously you have not read this RNS concerning the directors options.
I hope it does not affect your down bet but the RNS's are key for facts.
Exercise, Grant & Amendment of Options or Warrants
Mon, 16th Apr 2018 11:27
RNS Number : 0331L
UK Oil & Gas Investments PLC
16 April 2018
Γ
UK Oil & Gas Investments PLC
("UKOG" or the "Company")
Exercise, Grant and Amendment of Options or Warrants
UK Oil & Gas Investments PLC (London AIM: UKOG), announces the exercise of 1 million options, the grant of 17.5 million options and the amendment to the expiry date for certain options over ordinary shares granted in the 2015 option scheme.
Exercise of Warrants
UKOG announces that it has received notice of the exercise of warrants to subscribe for a total of 1,000,000 new ordinary shares in the Company (the "New Ordinary Shares"). The exercise price of the warrants was 0.4 pence. The Company has received ΓΒ£4,000 in respect of this exercise.
Application has been made for these New Ordinary Shares to be admitted to trading on AIM and it is anticipated that trading in such shares will commence on or around 20 April 2017.
Γ
Following Admission, the Company's enlarged issued share capital will comprise 3,835,466,771 ordinary shares. The Company does not hold any shares in treasury. This figure of 3,835,466,771 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
Grant and Amendment of Options
The Company also announces that it has granted options over 17.5 million shares in the capital of the Company. These options were granted to employees and consultants who are not Persons Discharging Managerial Responsibility ("PDMR") on behalf of the Company.
During its review of option awards the Independent Directors of the Company approved an extension of the exercise period of 25 million options previously granted to Stephen Sanderson (Chairman and Chief Executive Officer ("CEO")) and 10 million options granted to Matt Cartwright (Chief Operating Officer ("COO")).Γ
The independent directors determined that to ensure the continued alignment of the interests of shareholders and the option holders and considering the liquidity of the Company's shares it would be beneficial to extend these options rather than allow their exercise in the current open period and consider the grant of further options to both the CEO and COO.
As such the Independent Directors on 13/04/2018 have approved the extension of the term these options may be exercised from 31/12/2017 to 31/12/2019. All other terms and conditions relating to these options, including the exercise price, remain unchanged.
Due to publication of the Company's Annual Accounts on 29/03/2018, the Directors were deemed to be insi